717 related articles for article (PubMed ID: 16475209)
21. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
[TBL] [Abstract][Full Text] [Related]
22. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and outcome of thoracic neuroblastoma.
Häberle B; Hero B; Berthold F; von Schweinitz D
Eur J Pediatr Surg; 2002 Jun; 12(3):145-50. PubMed ID: 12101494
[TBL] [Abstract][Full Text] [Related]
24. [Hepatopathy in patients with stage 4S neuroblastoma].
Claviez A; Hero B; Schneppenheim R; Berthold F
Klin Padiatr; 1996; 208(4):221-8. PubMed ID: 8926687
[TBL] [Abstract][Full Text] [Related]
25. Neuroblastoma in Turkish children: experience of a single center.
Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
[TBL] [Abstract][Full Text] [Related]
26. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable?
Hayes-Jordan AA; Spunt SL; Poquette CA; Cain AM; Rao BN; Pappo AS; Shochat SJ
J Pediatr Surg; 2000 Jun; 35(6):948-53; discussion 953-4. PubMed ID: 10873042
[TBL] [Abstract][Full Text] [Related]
27. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
Kushner BH; Kramer K; LaQuaglia MP; Modak S; Cheung NK
Pediatr Blood Cancer; 2006 Mar; 46(3):278-84. PubMed ID: 16124002
[TBL] [Abstract][Full Text] [Related]
28. Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee.
Bisogno G; Compostella A; Ferrari A; Pastore G; Cecchetto G; Garaventa A; Indolfi P; De Sio L; Carli M
Cancer; 2012 Feb; 118(3):821-7. PubMed ID: 21751206
[TBL] [Abstract][Full Text] [Related]
29. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
London WB; Castleberry RP; Matthay KK; Look AT; Seeger RC; Shimada H; Thorner P; Brodeur G; Maris JM; Reynolds CP; Cohn SL
J Clin Oncol; 2005 Sep; 23(27):6459-65. PubMed ID: 16116153
[TBL] [Abstract][Full Text] [Related]
30. Pattern and outcome of neuroblastoma. A 10 year study.
Kusumakumary P; Ajithkumar TV; Ratheesan K; Chellam VG; Nair MK
Indian Pediatr; 1998 Mar; 35(3):223-9. PubMed ID: 9707875
[TBL] [Abstract][Full Text] [Related]
31. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma.
Mazzoleni S; Bisogno G; Garaventa A; Cecchetto G; Ferrari A; Sotti G; Donfrancesco A; Madon E; Casula L; Carli M;
Cancer; 2005 Jul; 104(1):183-90. PubMed ID: 15895378
[TBL] [Abstract][Full Text] [Related]
32. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
Fukuda M; Nozaki C; Ishiguro Y; Horibe K
Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
[TBL] [Abstract][Full Text] [Related]
33. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
34. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
36. Neuroblastoma in adults and adolescents: an indolent course with poor survival.
Franks LM; Bollen A; Seeger RC; Stram DO; Matthay KK
Cancer; 1997 May; 79(10):2028-35. PubMed ID: 9149032
[TBL] [Abstract][Full Text] [Related]
37. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
Mora J; Cheung NK; Chen L; Qin J; Gerald W
Cancer; 2001 Jan; 91(2):435-42. PubMed ID: 11180092
[TBL] [Abstract][Full Text] [Related]
38. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of therapy for stage C neuroblastoma.
Halperin EC
J Surg Oncol; 1996 Nov; 63(3):172-8. PubMed ID: 8944061
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
Kuroda T; Morikawa N; Matsuoka K; Fujino A; Honna T; Nakagawa A; Kumagai M; Masaki H; Saeki M
J Pediatr Surg; 2008 Dec; 43(12):2182-5. PubMed ID: 19040931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]